Celgene Corporation acquired Abraxis Bioscience in October 2010. Celgene is the owner of the trademark for Abraxane. Abraxis’ Abraxane drug has been used for treating metastatic breast cancer. CanDrug.com offers only genuine Abraxane. The Abraxane is manufactured by Abraxis Bioscience. This offer is neither endorsed nor authorized by Celgene Corporation and/or Abraxis Bioscience. CanDrug.com has no affiliation whatsoever with Celgene Corporation or Abraxis Bioscience.